Y.ora Vision Launches Following Licensing Agreement Between SERI and Eyexora Global to Advance Minimally Invasive Glaucoma Surgery

by Business Wire • 2025/10/16 • 0 Comments

SINGAPORE--(BUSINESS WIRE)-- #glaucoma--Y.ora Vision Launches Following Licensing Agreement Between SERI and Eyexora Global to Advance Minimally Invasive Glaucoma Surgery

← Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes →

Post navigation